Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Federal Trade Commission
Biotech
FTC tells Novo that Metsera offer may violate US merger law
The proposed purchase of Metsera by Novo "may violate the procedural provisions" of the Hart-Scott-Rodino Act, an FTC official wrote.
Eric Sagonowsky
Nov 5, 2025 4:26pm
FTC sues to block Surmodics acquisition over coating competition
Mar 7, 2025 11:00am
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy
Dec 7, 2023 11:26am
CooperSurgical calls off $875M Cook Medical deal amid FTC probe
Aug 3, 2023 10:57am
Boston Scientific nixes $230M M.I.Tech acquisition
May 25, 2023 12:59pm
Illumina sets deadline for proxy fight over board seats
Apr 21, 2023 10:35am
